Cargando…

Identification and Validation of an Individualized EMT-Related Prognostic Risk Score Formula in Gastric Adenocarcinoma Patients

BACKGROUND: The epithelial-mesenchymal transition (EMT) is a pivotal process for fibrotic disease, embryonic development, and wound healing. Moreover, some evidence has proven that the disorder of EMT also plays an important role in carcinogenesis, especially invasion and metastasis of various tumor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Deyu, Zhou, Siran, Liu, Bingrong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7142392/ https://www.ncbi.nlm.nih.gov/pubmed/32309437 http://dx.doi.org/10.1155/2020/7082408

Ejemplares similares

Identification and Validation of Three PDAC Subtypes and Individualized GSVA Immune Pathway-Related Prognostic Risk Score Formula in Pancreatic Ductal Adenocarcinoma Patients
por: Zhang, Deyu, et al.
Publicado: (2021)

Identification and Validation of EMT-Related lncRNA Prognostic Signature for Colorectal Cancer
por: Li, Danfeng, et al.
Publicado: (2021)

Identification of EMT-Related lncRNAs as Potential Prognostic Biomarkers and Therapeutic Targets for Pancreatic Adenocarcinoma
por: Deng, Yanyao, et al.
Publicado: (2022)

Identification of potential prognostic ceRNA module biomarkers in patients with pancreatic adenocarcinoma
por: Zhao, Lili, et al.
Publicado: (2017)

Endoscopic submucosal dissection for gastric ectopic pancreas: a single-center experience
por: Zhou, Yangyang, et al.
Publicado: (2019)

Identification of an EMT‐related gene‐based prognostic signature in osteosarcoma
por: Gong, Haoli, et al.
Publicado: (2023)

Identification and clinical validation of EMT-associated prognostic features based on hepatocellular carcinoma
por: Xu, Dafeng, et al.
Publicado: (2021)

Establishing and validating an ADCP-related prognostic signature in pancreatic ductal adenocarcinoma
por: Zhang, Deyu, et al.
Publicado: (2022)

Identification and validation of EMT-immune-related prognostic biomarkers CDKN2A, CMTM8 and ILK in colon cancer
por: Kang, Ning, et al.
Publicado: (2022)

Identification and validation of an individualized autophagy-clinical prognostic index in gastric cancer patients
por: Qiu, Jieping, et al.
Publicado: (2020)

Identification of a prognostic classifier based on EMT-related lncRNAs and the function of LINC01138 in tumor progression for lung adenocarcinoma
por: Xiao, Lingyan, et al.
Publicado: (2022)

Identification and validation of a prognostic risk-scoring model based on sphingolipid metabolism-associated cluster in colon adenocarcinoma
por: Yuan, Qihang, et al.
Publicado: (2022)

Identification of an EMT-Related Gene Signature for Predicting Overall Survival in Gastric Cancer
por: Dai, Weiyu, et al.
Publicado: (2021)

Identification of an Individualized Immune-Related Prognostic Risk Score in Lung Squamous Cell Cancer
por: Zhuang, Yuan, et al.
Publicado: (2021)

Validation of a New Prognostic Score in Patients with Ovarian Adenocarcinoma
por: Trifanescu, Oana Gabriela, et al.
Publicado: (2023)

Identification and Validation of a Pyroptosis-Related Prognostic Model for Gastric Cancer
por: Liang, Chaowei, et al.
Publicado: (2022)

Identification and validation of tumor microenvironment-related genes of prognostic value in lung adenocarcinoma
por: Yuan, Jingyan, et al.
Publicado: (2020)

Identification and Validation of Immune-Related LncRNA Prognostic Signature for Lung Adenocarcinoma
por: Wu, Guomin, et al.
Publicado: (2021)

Identification and Validation of Immune-Related Prognostic Genes in the Tumor Microenvironment of Colon Adenocarcinoma
por: Pan, Shenghua, et al.
Publicado: (2022)

Identification and validation of a necroptosis-related gene prognostic signature for colon adenocarcinoma
por: Zhang, Jingyao, et al.
Publicado: (2023)

Development and validation of glycolysis‐related prognostic score for prediction of prognosis and chemosensitivity of pancreatic ductal adenocarcinoma
por: Zhang, Xiu‐Ping, et al.
Publicado: (2021)

Prognostic impact of tumor budding and EMT in periampullary adenocarcinoma: a quantitative approach
por: Kocsmár, Éva, et al.
Publicado: (2020)

Identification and Validation of a GPX4-Related Immune Prognostic Signature for Lung Adenocarcinoma
por: Feng, Zhenxing, et al.
Publicado: (2022)

Identification and Validation of Prognostic Model for Pancreatic Ductal Adenocarcinoma Based on Necroptosis-Related Genes
por: Xie, Haoran, et al.
Publicado: (2022)

Identification and validation of a novel angiogenesis-related gene signature for predicting prognosis in gastric adenocarcinoma
por: Xu, Peipei, et al.
Publicado: (2023)

Identification of an Individualized Metabolism Prognostic Signature and Related Therapy Regimens in Early Stage Lung Adenocarcinoma
por: Hu, Junjie, et al.
Publicado: (2021)

Identification and Validation of an Inflammatory Response-Related Polygenic Risk Score as a Prognostic Marker in Hepatocellular Carcinoma
por: Xiaochun, Huang, et al.
Publicado: (2022)

Identification and validation of a novel redox-related lncRNA prognostic signature in lung adenocarcinoma
por: Ren, Jie, et al.
Publicado: (2021)

Identification and Validation a Necroptosis‑related Prognostic Signature and Associated Regulatory Axis in Stomach Adenocarcinoma
por: Wang, Ning, et al.
Publicado: (2021)

Identification and validation of a novel prognostic model of inflammation-related gene signature of lung adenocarcinoma
por: Luo, Dayuan, et al.
Publicado: (2022)

Identification and validation of a novel cuproptosis-related signature as a prognostic model for lung adenocarcinoma
por: Chen, Yuqiao, et al.
Publicado: (2022)

Identification and Validation of an EMT-Related LncRNA Signature for HNSCC to Predict Survival and Immune Landscapes
por: Feng, Chunyu, et al.
Publicado: (2022)

Identification and validation of a ferroptosis-related prognostic risk-scoring model and key genes in small cell lung cancer
por: Li, Suyang, et al.
Publicado: (2022)

Identification and validation of a novel necroptosis-related prognostic signature in cervical squamous cell carcinoma and endocervical adenocarcinoma
por: Zhang, Weiyu, et al.
Publicado: (2022)

Development and validation of an individual alternative splicing prognostic signature in gastric cancer
por: Lou, Shenghan, et al.
Publicado: (2021)

Retracted: Identification and Validation of an Inflammatory Response-Related Polygenic Risk Score as a Prognostic Marker in Hepatocellular Carcinoma
por: Markers, Disease
Publicado: (2023)

Identification and validation of critical genes with prognostic value in gastric cancer
por: Dong, Ningxin, et al.
Publicado: (2022)

Identification and Validation of a Novel Necroptosis-Related Long Noncoding RNA Prognostic Signature for Lung Adenocarcinoma
por: Zeng, Cheng, et al.
Publicado: (2022)

Identification and validation of novel lung adenocarcinoma subtypes and construction of prognostic models: based on cuprotosis-related genes
por: Wang, Guangyao, et al.
Publicado: (2023)

Identification of disulfidptosis-related subgroups and prognostic signatures in lung adenocarcinoma using machine learning and experimental validation
por: Wang, Yuzhi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4tkv406k3uh07fllu4so7tst5b